New Agents Cure HCV After Transplant

November 14, 2014 4:27 PM

13 0

BOSTON -- Evidence is mounting that new direct-acting agents against hepatitis C (HCV) can cure the disease when it recurs after liver transplant.

HCV is the leading indication for liver transplant in the U.S., but the virus always re-infects the new liver, often leading quickly to cirrhosis and even graft loss.

Read more

To category page